Journal Highlights
P.N.E.I.: life and death of skin cells. A new paradigm in the treatment of vitiligo: the low dose cytokines therapy
T. Rivkina,
T. Rivkina
University of Rome “G. Marconi”, Rome
Search for more papers by this author J. Hercogova,
J. Hercogova
Department of Dermatology, 2nd Medical School, Charles University, Prague
Search for more papers by this author Torello Lotti,
Corresponding Author
Torello Lotti
Dermatology, University of Rome “G. Marconi” Rome, Italy
Institute of Dermatology LifeCronos, Florence, Italy
World Health Academy Foundation, Zurich (CH)
Address correspondence and reprint requests to: Torello Lotti, MD, Director, Institute of Dermatology LifeCronos, Florence, Italy, or email:
[email protected].
Search for more papers by this author
T. Rivkina,
T. Rivkina
University of Rome “G. Marconi”, Rome
Search for more papers by this author J. Hercogova,
J. Hercogova
Department of Dermatology, 2nd Medical School, Charles University, Prague
Search for more papers by this author Torello Lotti,
Corresponding Author
Torello Lotti
Dermatology, University of Rome “G. Marconi” Rome, Italy
Institute of Dermatology LifeCronos, Florence, Italy
World Health Academy Foundation, Zurich (CH)
Address correspondence and reprint requests to: Torello Lotti, MD, Director, Institute of Dermatology LifeCronos, Florence, Italy, or email:
[email protected].
Search for more papers by this author
First published: 24 August 2015
No abstract is available for this article.
References
- 1
Barygina V,
Becatti M,
Lotti T,
Moretti S,
Taddei N,
Fiorillo C. Treatment with low-dose cytokines reduces oxidative- mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci 2015. [Epub ahead of print].
- 2
Lotti T,
Hercogova J,
Wollina U, et al. Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents 2015: 29 (1 Suppl): 53–8.
- 3
Lotti T,
Zanardelli M,
D'Erme AM. Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr 2014: 164 (13–14): 278–85.
- 4
Laddha NC,
Dwivedi M,
Mansuri MS, et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 2013: 22 (4): 245–250.
- 5
Lotti T,
Perra A. Vitiligo, P.N.E.I. and low dose cytokines and growth factors. J Pigmentary Disord 2014: 1: 5.
